Gabriel Revon-Rivière

11PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 29, 2025
Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor.

Caroline Donze, Anissa Hamani, Gabriel Revon-Riviere

|Aug 01, 2025
Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

Denise M Connolly, Gabriel Revon-Rivière, Rose Chami

|Jan 25, 2025
Striped Hair Colour Change on Tovorafenib in an 18-Year-Old Boy With a Brainstem Low-Grade Glioma.

Nicolas André, Caroline Donzé, Gabriel Revon-Rivière

|Nov 06, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.

Gemma Bryan, Louise Guolla, Gabriela Inés Villanueva

|Oct 19, 2024
Upfront immunotherapy for synchronous high-grade glioma and B-lymphoma in a pediatric patient with CMMRD syndrome.

Thérèse De Vanssay, Nour El Riachy, Caroline Donze

|Sep 04, 2024
Comment on: Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer.

Gabriel Revon-Riviere, Denise Connolly, Sarah Cohen-Gogo

Pageof 2

Frequent Collaborators

5 joint publications

Sarah Cohen-Gogo

4 joint publications

Nicolas André

3 joint publications

Daniel A Morgenstern

3 joint publications

Caroline Donze